Lv21
104 积分 2026-07-22 加入
Review for "Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting"
5天前
已关闭
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
5天前
已完结
Current opinions in immune checkpoint inhibitors rechallenge in solid cancers
5天前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
6天前
已完结
Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review
6天前
已完结
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study
6天前
已完结
Systemic therapy for duodenal adenocarcinoma: An analysis of the National Cancer Database (NCDB)
7天前
已关闭
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis
9天前
已完结
Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma
13天前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
14天前
已完结
皖公网安备34019202002308
